Summary & Overview
HCPCS Level II C8918: Magnetic Resonance Angiography with Contrast, Pelvis
HCPCS Level II code C8918 represents contrast-enhanced magnetic resonance angiography (MRA) of the pelvis, a diagnostic imaging procedure used to assess pelvic arterial and venous anatomy and detect stenosis, occlusion, or aneurysmal disease. Nationally, MRA of the pelvis is an important noninvasive alternative to catheter angiography, influencing care pathways for vascular and oncologic patients and affecting imaging utilization and reimbursement patterns across payers.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national view of clinical context for pelvic MRA, common site-of-service considerations, and the payer landscape addressed in the analysis. The publication outlines benchmarks for utilization and payment where available, summarizes relevant policy and coverage features that affect access and billing, and explains coding and documentation considerations relevant to claims processing for pelvic contrast-enhanced MRA.
The report is organized to help coders, billing managers, and policy analysts understand where C8918 fits in imaging service lines, typical settings for performance, and payer-related factors that commonly influence authorization and claim adjudication. Data not provided in the input are noted explicitly where applicable.
Billing Code Overview
HCPCS Level II code C8918 describes magnetic resonance angiography with contrast, pelvis. This service involves contrast-enhanced MR imaging focused on the pelvic vasculature to evaluate arterial and venous anatomy, stenosis, occlusion, or other vascular pathology. The service type is diagnostic imaging (contrast-enhanced magnetic resonance angiography). The typical site of service is an outpatient imaging center or hospital outpatient radiology department.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of peripheral arterial disease and chronic pelvic ischemic pain is referred for C8918 — magnetic resonance angiography with contrast of the pelvis — to evaluate pelvic arterial anatomy and identify stenosis, occlusion, or aneurysm. The typical clinical workflow begins with an outpatient order from a vascular surgeon, interventional radiologist, or primary care clinician. Pre-procedure steps include screening for MRI contraindications (implanted devices, severe claustrophobia), assessing renal function (eGFR) for gadolinium-based contrast safety, and obtaining informed consent. On the day of service the patient arrives to an outpatient imaging center or hospital radiology department; an MRI technologist reviews screening, places IV access, and performs the contrast-enhanced pelvic MRA protocol. Images are processed and interpreted by a radiologist (diagnostic read), who issues a final report documenting arterial findings and procedural details. Post-procedure monitoring is brief for contrast reaction observation; results are communicated to the referring clinician for management planning such as medical therapy, endovascular intervention, or surgical referral.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation of the pelvic MRA separated from technical services. |